1 Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: A review of ticagrelor Clinical Pharmacology: Advances and Applications, October 31, 2013 Free full text Review Article
2 Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes The American Journal of Cardiology, April 4, 2014
3 Favourable 5-year postdischarge survival of comatose patients resuscitated from out-of-hospital cardiac arrest, managed with immediate coronary angiogram on admission European Heart Journal: Acute Cardiovascular Care, February 27, 2014
4 Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non–ST-segment–elevation acute coronary syndromes or stable ischemic heart disease Circulation: Cardiovascular Interventions, June 20, 2014
5 Incidence and outcome of high on-treatment platelet reactivity in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the vip [verifynow and inhibition of platelet reactivity] study) The American Journal of Cardiology, September 6, 2013
Question: True or false: In patients with STEMI, an investigational trial of IV glucose-insulin-potassium treatment significantly reduced the risk of composites cardiac arrest and/or mortality with and without HF hospitalization within 1 year.